PROSPECTIVE COMPARISON OF ARNI [ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITOR] WITH ACEI [ANGIOTENSIN CONVERTING-ENZYME INHIBITOR] TO DETERMINE IMPACT ON GLOBAL MORTALITY AND MORBIDITY IN HEART FAILURE TRIAL
Источник: McMurray J.J., Packer M., Desai A.S., et al. Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure. N. Engl. J. Med. – 2014. – Vol. 371. – P. 993–1004.
Saved in:
| Format: | Article |
|---|---|
| Language: | Russian |
| Published: |
Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department
2016-02-01
|
| Series: | Неотложная медицинская помощь |
| Online Access: | https://www.jnmp.ru/jour/article/view/61 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Angiotensin Receptor–Neprilysin Inhibitor in Heart Failure Patients With Renal Dysfunction
by: Xiaogang Zhu, et al.
Published: (2024-01-01) -
Use of angiotensin receptor – neprilysin inhibitors in heart failure: a paradigm shift
by: M. O.E. Irhuma, et al.
Published: (2016-11-01) -
Angiotensin receptor‐neprilysin inhibitor adherence and outcomes in heart failure with reduced ejection fraction
by: Dong‐Hyuk Cho, et al.
Published: (2025-02-01) -
Angiotensin Receptor‐Neprilysin Inhibitor Is Associated With Improved Cardiac Autonomic Function in Heart Failure
by: Andreas A. Boehmer, et al.
Published: (2024-08-01) -
Comparative analysis of mineralocorticoid receptor antagonists and renin-angiotensin system inhibitors/angiotensin receptor neprilysin inhibitor in heart failure with mildly reduced ejection fraction
by: Chia-Chen Lee, et al.
Published: (2024-12-01)